Hledat | SPORTIVO Network

harshasharma added blog Networking
2026-04-27 08:59:24

Antibody-Drug Conjugate (ADC) Oncology Market: Insights, Key Players, and Growth Analysis
Antibody-Drug Conjugate (ADC) Oncology Market Summary: According to the latest report published by Data Bridge Market Research, the Antibody-Drug Conjugate (ADC) Oncology Market CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of...

0 Komentáře 0 Sdílení 456 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
sonalisonkusare added blog Other
2026-03-20 12:42:22

Clinical Oncology Next Generation Sequencing Market In-Depth Research Report with Industry Forecast
"Global Executive Summary Clinical Oncology Next Generation Sequencing Market Market: Size, Share, and Forecast Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. The complete...

0 Komentáře 0 Sdílení 1K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
harshasharma added blog Networking
2026-04-29 04:43:16

Immuno Oncology Assays Market Overview: Key Drivers and Challenges
Immuno Oncology Assays Market Summary: According to the latest report published by Data Bridge Market Research, the Immuno Oncology Assays Market CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period DBMR...

0 Komentáře 0 Sdílení 222 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
harshasharma added blog Other
2026-03-10 08:44:52

Immuno Oncology Assays Market: Insights and Competitive Analysis
Executive Summary Immuno Oncology Assays Market Size and Share Across Top Segments CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period To better structure this Immuno Oncology Assays report, a nice blend of...

0 Komentáře 0 Sdílení 444 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
dbmr456 added blog Other
2026-03-17 08:54:30

Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032
Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...

0 Komentáře 0 Sdílení 632 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
rishika_2003 added blog Health
2026-03-13 10:16:02

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Komentáře 0 Sdílení 7K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
jessicapinedaw added blog Health
2026-05-07 15:24:44

5-Fluorouracil Market Growth Analysis: Expanding Applications in Oncology Therapeutics
The 5-Fluorouracil (5-FU) Market is poised for steady expansion through 2034, supported by the rising global burden of cancer, increasing chemotherapy adoption, and the growing role of generic oncology drugs. 5-Fluorouracil remains one of the most widely used antimetabolite chemotherapy agents, particularly in the treatment of colorectal, breast, gastrointestinal, pancreatic, and head &...

0 Komentáře 0 Sdílení 252 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
PrathameshGavade added blog Domů
2025-10-08 07:02:25

Advances in Molecular Oncology Diagnostics Market : Understanding the Market and Its Potential
The Global Molecular Oncology Diagnostics Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Molecular Oncology Diagnostics Market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth...

0 Komentáře 0 Sdílení 4K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
VIshalkumar009 added blog Domů
2026-03-11 10:10:55

Antibody Drug Conjugates (ADCs) Market Insights 2026: Precision Oncology Transformation
The landscape of cancer treatment is undergoing a seismic shift. Gone are the days when "scorched earth" chemotherapy was the only viable path for late-stage patients. Today, we are living in the era of the "magic bullet" , a concept first envisioned by Paul Ehrlich over a century ago now realized through the Antibody Drug Conjugates (ADCs) Market. By combining the laser-like precision of...

0 Komentáře 0 Sdílení 977 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
harshasharma added blog Networking
2026-05-22 07:58:17

Antibody-Drug Conjugate (ADC) Oncology Market Overview: Key Drivers and Challenges
Antibody-Drug Conjugate (ADC) Oncology Market Summary: According to the latest report published by Data Bridge Market Research, the Antibody-Drug Conjugate (ADC) Oncology Market CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of...

0 Komentáře 0 Sdílení 77 Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
priyanka added blog Other
2025-11-27 07:53:48

Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine Applications
The global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...

0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
priyanka added blog Other
2025-11-27 07:54:44

Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine Applications
The global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...

0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
stephengrey169 added blog Other
2026-03-24 13:22:33

Accelerating Cancer Research: Patient Derived Xenograft Model Market Opportunities, Size & Forecast 2031
The Patient‑Derived Xenograft Model Market is becoming a critical pillar in oncology research and drug discovery as global demand for predictive preclinical platforms continues to rise. According to the latest market intelligence, the Patient‑Derived Xenograft Model Market was valued at US$ 468.75 million in 2024 and is projected to reach US$ 1,119.36 million by 2031, reflecting a compound...

0 Komentáře 0 Sdílení 1K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
Kumud added blog Health
2026-03-31 12:16:07

All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
naznins407 added blog Health
2026-02-26 08:22:57

Anti-Radiation Drugs Market Size, Share, and Strategic Outlook
Advancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...

0 Komentáře 0 Sdílení 5K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
Kumud added blog Health
2026-03-27 12:55:09

Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...

0 Komentáře 0 Sdílení 4K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
Kumud added blog Health
2026-04-07 12:36:34

Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%
According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...

0 Komentáře 0 Sdílení 2K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
Kumud added blog Health
2026-04-08 12:58:09

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Komentáře 0 Sdílení 1K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
Kumud added blog Health
2026-04-08 13:01:29

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Komentáře 0 Sdílení 1K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
NikitaG added blog Other
2025-12-10 07:24:21

Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032
“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...

0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!
rishika_2003 added blog Health
2026-03-13 09:33:39

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

1

0 Komentáře 0 Sdílení 3K Shlédnutí 0 Hodnocení

Please log in to like, share and comment!

More Results